Trial Profile
ATLANTIC
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2010
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ATLANTIC
- 22 Sep 2010 Results have been presented at the 46th European Association for the Study of Diabetes (EASD) according to a sanofi aventis media release.
- 22 Sep 2010 New trial record
- 20 Sep 2010 Results were presented at the 46th European Association for the Study of Diabetes (EASD) Annual Meeting.